Shilpa Medicare Gains On Receiving Nod For COVID-19 Adjunct Therapy Drug
2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients, Shilpa Medicare added.
from NDTV Profit - Latest https://ift.tt/38rpZdn
2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients, Shilpa Medicare added.
from NDTV Profit - Latest https://ift.tt/38rpZdn
2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients, Shilpa Medicare added.
Comments
Post a Comment